Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $328.05 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $312.26 | 22 | $0 (2020) |
| HOLOGIC INC | $15.79 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $32.12 | 2 | Gilead Sciences, Inc. ($16.33) |
| 2019 | $88.64 | 6 | Gilead Sciences, Inc. ($88.64) |
| 2018 | $125.31 | 9 | Gilead Sciences, Inc. ($125.31) |
| 2017 | $81.98 | 6 | Gilead Sciences Inc ($81.98) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2020 | HOLOGIC INC | Atec (Device), Eviva | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Breast and Skeletal Health | ||||||
| 02/19/2020 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: HBV | ||||||
| 12/18/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: HBV | ||||||
| 11/20/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: HBV | ||||||
| 10/16/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: HBV | ||||||
| 05/15/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: HBV | ||||||
| 03/20/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: HBV | ||||||
| 01/16/2019 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: HBV | ||||||
| 12/19/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: HBV | ||||||
| 11/21/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: HBV | ||||||
| 08/29/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.66 | General |
| 06/20/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: HCV | ||||||
| 05/16/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.13 | General |
| 04/18/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: HCV | ||||||
| 03/21/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.36 | General |
| 02/21/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.04 | General |
| 01/17/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 12/20/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $14.52 | General |
| 11/15/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $12.93 | General |
| 10/18/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $10.37 | General |
| 07/19/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $15.28 | General |
| 04/19/2017 | Gilead Sciences Inc | Harvoni (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: HCV | ||||||
| 01/18/2017 | Gilead Sciences Inc | Harvoni (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: HCV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 104 | 1,320 | $13,743 | $2,719 |
| 2022 | 3 | 57 | 58 | $5,952 | $1,316 |
| 2021 | 4 | 132 | 147 | $15,785 | $3,734 |
| 2020 | 3 | 63 | 92 | $13,897 | $3,525 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 11 | 12 | $5,347 | $924.92 | 17.3% |
| 77067 | Screening mammography | Office | 2023 | 25 | 25 | $3,405 | $809.13 | 23.8% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 24 | 24 | $2,677 | $642.81 | 24.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 33 | 34 | $1,432 | $204.57 | 14.3% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 11 | 1,225 | $882.00 | $137.33 | 15.6% |
| 77067 | Screening mammography | Office | 2022 | 21 | 21 | $2,891 | $662.48 | 22.9% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 21 | 21 | $2,349 | $559.96 | 23.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 15 | 16 | $712.00 | $93.42 | 13.1% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 25 | 33 | $6,693 | $1,323 | 19.8% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 24 | 31 | $3,340 | $649.35 | 19.4% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 25 | 25 | $700.00 | $483.25 | 69.0% |
| 77067 | Screening mammography of both breasts | Facility | 2021 | 18 | 18 | $2,538 | $482.64 | 19.0% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 23 | 23 | $644.00 | $444.59 | 69.0% |
| 77063 | Screening digital tomography of both breasts | Facility | 2021 | 17 | 17 | $1,870 | $351.34 | 18.8% |
| 77067 | Mammography of both breasts | Office | 2020 | 24 | 41 | $9,824 | $2,578 | 26.2% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 19 | 31 | $3,253 | $823.89 | 25.3% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 20 | 20 | $820.00 | $122.93 | 15.0% |
About Dr. Johanne Leblanc, M.D
Dr. Johanne Leblanc, M.D is a Diagnostic Radiology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942352026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Johanne Leblanc, M.D has received a total of $328.05 in payments from pharmaceutical and medical device companies, with $32.12 received in 2020. These payments were reported across 23 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($328.05).
As a Medicare-enrolled provider, Leblanc has provided services to 356 Medicare beneficiaries, totaling 1,617 services with total Medicare billing of $11,294. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Seattle, WA
- Active Since 01/17/2007
- Last Updated 04/26/2021
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1942352026
Products in Payments
- Vemlidy (Drug) $133.95
- Harvoni (Drug) $28.88
- Epclusa (Drug) $28.09
- Atec (Device) $15.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Seattle
Guy Johnson
Diagnostic Radiology — Payments: $194,038
Dr. Dushyant Sahani, Md, MD
Diagnostic Radiology — Payments: $152,032
Eniola Oluyemi, Md, MD
Diagnostic Radiology — Payments: $146,823
Marissa Lawson, Md, MD
Diagnostic Radiology — Payments: $141,917
Nathan Cross, Md, MD
Diagnostic Radiology — Payments: $141,035
Dr. Kathryn Lowry, M.d, M.D
Diagnostic Radiology — Payments: $80,445